Showing results (51-60 of 113) with videos related to
Sort By:
Pageof 12
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 21, 2017
Dynorphin Counteracts Orexin in the Paraventricular Nucleus of the Thalamus: Cellular and Behavioral EvidenceAlessandra Matzeu, Marsida Kallupi, Olivier George, et al.The Journal of Pharmacology and Experimental Therapeutics|February 28, 2002
Reversal of ethanol-seeking behavior by D1 and D2 antagonists in an animal model of relapse: differences in antagonist potency in previously ethanol-dependent versus nondependent ratsXiu Liu, Friedbert WeissPsychopharmacology|November 26, 2002
Stimulus conditioned to foot-shock stress reinstates alcohol-seeking behavior in an animal model of relapseXiu Liu, Friedbert WeissThe Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 30, 2002
Behavioral neurobiology of alcohol addiction: recent advances and challengesFriedbert Weiss, Linda J PorrinoNeuropharmacology|March 28, 2022
Blockade of corticotropin-releasing factor-1 receptors in the infralimbic cortex prevents stress-induced reinstatement of alcohol seeking in male Wistar rats: Evidence of interaction between CRF1 and orexin receptor signalingFrancisco J Flores-Ramirez, Alessandra Matzeu, Laura Sánchez-Marín, et al.Scientific Reports|March 9, 2024
LY2444296, a κ-opioid receptor antagonist, selectively reduces alcohol drinking in male and female Wistar rats with a history of alcohol dependenceFrancisco J Flores-Ramirez, Jessica M Illenberger, Glenn Pascasio, et al.The Journal of Pharmacology and Experimental Therapeutics|June 25, 2017
Cebranopadol Blocks the Escalation of Cocaine Intake and Conditioned Reinstatement of Cocaine Seeking in RatsGiordano de Guglielmo, Alessandra Matzeu, Jenni Kononoff, et al.Neuropharmacology|August 14, 2023
Daily treatment with the dual orexin receptor antagonist DORA-12 during oxycodone abstinence decreases oxycodone conditioned reinstatementJessica M Illenberger, Francisco J Flores-Ramirez, Glenn Pascasio, et al.Neuropharmacology|July 18, 2023
ADX106772, an mGlu2 receptor positive allosteric modulator, selectively attenuates oxycodone taking and seekingJessica M Illenberger, Francisco J Flores-Ramirez, Alessandra Matzeu, et al.Alcoholism, Clinical and Experimental Research|September 1, 2007
Remission and resurgence of anxiety-like behavior across protracted withdrawal stages in ethanol-dependent ratsYu Zhao, Friedbert Weiss, Eric P ZorrillaPageof 12